Skip to content

CFDs are complex financial instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money. CFDs are complex financial instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.

Why the EML share price is down 37% in the last month

We examine what caused the stock to crash and how a number of key analysts responded.

Why the EML share price is down 37% in the last month Source: Bloomberg

Regulatory concerns

It’s been a horror month for EML Payments (ticker: EML), with the stock down close to 40% after the Central Bank of Ireland (CBI) raised ‘significant’ regulatory concerns in regards to how EML’s Irish subsidiary – PFS Card Services AML/CTF – risk and control frameworks and governance.

The company noted that the CBI was ‘minded’ to issue directions in relation to the concerns raised, with management adding that if such directions were made they may have a material impact on the company’s European business and as a corollary, global operating performance.

Illustrating that point, the company told the market that 'During the period from 1 January 2021 to 31 March 2021, EML estimates that approximately 27% of EML's global consolidated revenue (unaudited) derived from programs operating under PCSIL's Irish authorisation.'

Macquarie constructive, Canaccord cautious

Importantly however, as analysts from Macquarie pointed out, recent enforcements from the Irish Central Bank has not led to the removal of licenses. Rather, the CBI has sought settlements, with the average settlement since 2019 standing at approximately €1.5 million.

Based on the investment bank's base case, which assumes EML will satisfactorily 'respond to the CBI’s concerns and be able to continue operating, albeit with an increase to its existing cost base', Macquarie reiterated their Outperform rating and $4.00 price target on EML.

Despite that, the short-term is likely to be marred by uncertainty, with Macquarie analysts adding:

‘We recognise uncertainty will weigh on the stock near term and this will serve as a reminder of the risks and opacity associated with the business driving a de-rating.’

Management stressed that these concerns had no bearing on its Australian, UK or North American operations, as well as the company's other Irish subsidiary, EML Money DAC.

Analysts from Canaccord Genuity took a more conservative stance, lowering their rating from Buy to Hold, on the basis of ‘expected overhang in the stock and large range of unexpected outcomes.’

EML share price out of favour

In spite of EML management’s commentary and Macquarie’s optimism, with almost a third of the company’s revenue at stake, its unsurprising that the stock was sold-off heavily by investors in response.

The day before that initial announcement, the stock closed at $5.15 per share, not too far off the company’s 52-week high. Investors rushed for the exit on the day of the announcement: the stock opened at $2.66 per share and at its intraday low was down as much as 52% from the prior close.

Over the next seven sessions the stock would rebound, if only somewhat, last trading around the $3.49 mark. At those price levels the stock remains down 37% in the last month.

Trade stocks like EML long and short with IG today

Create an IG account or log in to your existing account to get started now


This information has been prepared by IG, a trading name of IG Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.
CFDs are a leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your initial deposit, so please ensure that you fully understand the risks involved.

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Friday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.